The primary objective is to evaluate whether clinical opinion of product performance results in expected wound response and outcomes when using the Medela Invia Motion Endure NPWT system during 4-week study duration.~* Goal of therapy will be defined by the physician according to initial assessment:~Endpoints (dependent on goal of therapy):~Decrease in wound volume~Decrease in size of the tunneling area~Decrease in size of undermining~Decrease in amount of slough~Increase in granulation tissue~Decrease in edema/periwound swelling~The wound bed is progressing acceptably towards a transition to another treatment modality such as Moist Wound Healing (MWH), surgical closure, or a flap or graft.~**Study endpoint will be determined by physician at the time of enrollment, when the goal of therapy is documented**
The purpose of this study is to determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.